Trump urged not to relax drug regulations

Moves to deregulate America’s drug-approval process could see a flood of unproven and even harmful new drugs enter the market that could threaten human health, experts say.

The warning follows a speech to Congress last week by President Donald Trump, in which he said the US Food and Drug Administration’s drug-approval process was “too slow and burdensome”, and promised to “slash the restraints”.

Trump’s claims reinforce comments he made in January to pharmaceutical industry executives, where he said: “We’re going to